You are here

Safety And Efficacy Of Exubera Compared With Subcutaneous Human Insulin Therapy In Children And Adolescents

Last updated on February 22, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Buffalo, New York, 14222 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Type 1 Diabetes Mellitus
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
6-17 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Subjects with Type 1 diabetes mellitus for more than 6 months.

- Males and females ages 6 to 17 years.

- Subjects should be receiving, or be able to tolerate, at a minimum a 3 unit pre
prandial dose of short acting subcutaneous insulin.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Subjects using an insulin pump

- Smoking

NCT00479258
Pfizer
Terminated
Safety And Efficacy Of Exubera Compared With Subcutaneous Human Insulin Therapy In Children And Adolescents

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

Type 1 Diabetes Mellitus
NCT00479258
All Genders
6+
Years
Buffalo, New York
Type 1 Diabetes Mellitus
NCT00356421
All Genders
18+
Years
Multiple Sites
Type 1 Diabetes Mellitus
NCT00424333
All Genders
12+
Years
Multiple Sites
Type 1 Diabetes Mellitus
NCT00424437
All Genders
12+
Years
Multiple Sites

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now